Table 1. Demographic, cognitive, and medication adherence profiles of stroke survivors at five years post-stroke.
Demographics | N (%) | |
Sex (n = 108) | Male | 73 (67.6) |
Female | 35 (32.4) | |
Marital status (n = 101) | Married/cohabiting | 65 (64.4) |
Single/widowed/divorced | 36 (35.6) | |
Living arrangements (n = 100) | Living alone | 26 (26.0) |
Living with others | 71 (71.0) | |
Nursing home resident | 3 (3.0) | |
Occupational status (n = 94) | Working full-time or part-time | 18 (19.2) |
Not working | 76 (80.9) | |
Education (n = 98) | Primary school | 31 (31.6) |
Secondary school | 42 (42.9) | |
Third level | 25 (25.5) | |
Cognitive impairment |
Impaired N (%) |
|
Memory (n = 100) | HVLT total recall | 23 (23.0) |
Executive function (n = 102) | Semantic fluency | 22 (21.6) |
Letter fluency | 28 (27.5) | |
Digit symbol coding (n = 96) | 31 (32.3) | |
Trail Making Test–A (n = 93) | 14 (15.1) | |
Trail Making Test–B (n = 92) | 23 (25.0) | |
Composite executive function | 24 (23.8) | |
Impaired in both NINDS domains (n = 102) | 11 (10.8) | |
Impaired in at least one NINDS domain (n = 102) | 36 (35.6) | |
MoCA <24 (n = 101) | 46 (45.5) | |
Medication adherence |
Non-adherent N (%) |
|
Prescription refills (PDC<80%) (n = 53) | Lipid modifiers | 8 (15.1%) |
Antithrombotics | 16 (30.2%) | |
Antihypertensives | 12 (22.6%) | |
Self-report (MARS) (n = 95) | 51 (53.7%) |
NINDS: National Institute of Neurological Disorders and Stroke. MoCA: Montreal Cognitive Assessment. MARS: Medication Adherence Report Scale.